11月27日，新诺威盘中上涨2.03%，截至09:52，报33.75元/股，成交8671.37万元，换手率0.19%，总市 值474.05亿元。 截至10月31日，新诺威股东户数2.18万，较上期增加32.87%；人均流通股57116股，较上期减少 24.74%。2025年1月-9月，新诺威实现营业收入15.93亿元，同比增长7.71%；归母净利润-2404.89万元， 同比减少117.26%。 分红方面，新诺威A股上市后累计派现6.51亿元。近三年，累计派现5.00亿元。 机构持仓方面，截止2025年9月30日，新诺威十大流通股东中，香港中央结算有限公司位居第二大流通 股东，持股1778.22万股，相比上期减少321.69万股。中欧医疗健康混合A（003095）位居第三大流通股 东，持股1632.25万股，相比上期减少386.14万股。工银前沿医疗股票A（001717）位居第四大流通股 东，持股1400.01万股，相比上期增加200.01万股。汇添富创新医药混合A（006113）位居第五大流通股 东，持股1227.70万股，相比上期增加248.44万股。易方达创业板ETF（159915）位居第九大流通股东， ...

Group 1 - The ChiNext Index has shown strong performance, rising by 1.33% as of November 26, 2025, with notable gains in constituent stocks such as Maiwei Co., Ltd. (up 10.59%) and Zhongji Xuchuang (up 9.40%) [1] - The ChiNext ETF by Bosera has increased by 7.80% over the past three months, with a latest price of 2.81 yuan and a turnover rate of 1.63% on November 26, 2025 [1][3] - The optical module (CPO) index rose by 3.01% on November 26, 2025, with institutional funds seeing a net inflow of 34.13 billion yuan [1] Group 2 - The communication industry has performed exceptionally well in 2025, with a year-to-date increase of 55.58%, ranking second among all industries, and institutional holdings have significantly increased [2] - The GB300 platform is expected to ramp up production in Q4, leading to large-scale shipments of 1.6T optical modules, with silicon photonics technology projected to capture nearly 60% of the global optical module market by 2030 [2] - Public fund holdings in the communication sector have surpassed 6.5%, a historical high, while valuations remain relatively low, not fully reflecting the sector's high growth potential [2]

Core Viewpoint - The innovative drug sector is experiencing significant activity, with multiple companies reaching their daily price limits. Group 1: Company Performance - Zhongheng Group, Fuyuan Pharmaceutical, Hainan Haiyao, and Peking University Pharmaceutical have all hit the daily limit up [1] - Xinhua Pharmaceutical, ST Xiangxue, and Xinnowei are among the stocks with notable gains [1]

Group 1 - The core point of the article highlights the recent performance of XinNuoWei, which saw a 5.2% increase in stock price, reaching 33.39 CNY per share, with a total market capitalization of 46.899 billion CNY [1] - XinNuoWei's main business involves the research, production, and sales of functional foods, with revenue composition being 88.93% from functional foods and raw materials, 8.91% from biopharmaceuticals, and 2.16% from other sources [1] Group 2 - From the perspective of major fund holdings, data shows that Nuoan Fund has a significant position in XinNuoWei, with its Nuoan Selected Value Mixed A Fund increasing its holdings by 470,600 shares in the third quarter, now holding a total of 954,300 shares, which constitutes 4.9% of the fund's net value [2] - The Nuoan Selected Value Mixed A Fund has achieved a year-to-date return of 73.05%, ranking 163 out of 8,134 in its category, and a one-year return of 57.82%, ranking 429 out of 8,056 [2] - The fund manager, Tang Chen, has been in charge for 2 years and 343 days, with the fund's total asset size at 1.317 billion CNY, achieving a best return of 76.25% during his tenure [2]

Core Viewpoint - New Nuo Wei's stock price has shown a significant increase of 21.00% year-to-date, despite recent declines in the short term [1][2]. Company Overview - New Nuo Wei, established on April 5, 2006, and listed on March 22, 2019, is located in Shijiazhuang, Hebei Province. The company specializes in the research, production, and sales of functional foods, with revenue composition as follows: 88.93% from functional foods and raw materials, 8.91% from biopharmaceuticals, and 2.16% from other sources [1][2]. Financial Performance - For the period from January to September 2025, New Nuo Wei reported a revenue of 1.593 billion yuan, reflecting a year-on-year growth of 7.71%. However, the net profit attributable to the parent company was a loss of 24.049 million yuan, a decrease of 117.26% compared to the previous year [2][3]. Shareholder Information - As of October 31, the number of shareholders for New Nuo Wei increased by 32.87% to 21,800, with an average of 57,116 circulating shares per shareholder, down by 24.74% [2][3]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited holding 17.7822 million shares, a decrease of 3.2169 million shares from the previous period [3].

2025年11月21日，A股三大股指集体大幅跳空低开。截至10:14，中证主要消费指数下跌0.24%。成分股 方面涨跌互现，东鹏饮料领涨1.73%，北大荒上涨1.14%，新诺威上涨1.00%；金龙鱼领跌，贝泰妮、安 迪苏跟跌。 消息面方面，近期白酒价格有所回暖，包括茅台在内的各款白酒，电商售价都有不同程度地回升，飞天 茅台线下零售价回到1700元/瓶以上。值得注意的是，经过近期调整，白酒板块的股价已经处在相对低 位。不少机构认为，当前或为吃喝板块较好布局时机。 从估值层面来看，消费ETF嘉实跟踪的中证主要消费指数最新市盈率（PE-TTM）仅20.25倍，处于近3 年20%的分位，即估值低于近3年80%以上的时间，处于历史低位。 场外投资者还可以通过消费ETF联接基金（009180）布局消费复苏行情。 中信证券食品饮料行业2026年投资策略研报称，绝大部分大众品行业需求经历了连续2年量价齐跌，同 时渠道端库存基本完成挤水分而逐步恢复至良性健康水平，同时结合2025年三季度大众品需求环比企稳 趋势以及考虑到2026年是消费大年（2026年春节备货和2027年春节备货绝大部分都将反映在2026年）， 看好大众品20 ...

Core Viewpoint - New Nuo Wei's stock price has shown volatility, with a year-to-date increase of 21.98% but a significant decline of 33.69% over the past 60 days, indicating potential market concerns and investor sentiment shifts [1][2]. Financial Performance - For the period from January to September 2025, New Nuo Wei reported a revenue of 1.593 billion yuan, reflecting a year-on-year growth of 7.71%. However, the net profit attributable to shareholders was a loss of 24.049 million yuan, a decrease of 117.26% compared to the previous year [2]. - Since its A-share listing, New Nuo Wei has distributed a total of 651 million yuan in dividends, with 500 million yuan distributed over the last three years [3]. Shareholder and Market Activity - As of October 31, 2025, the number of shareholders for New Nuo Wei increased by 32.87% to 21,800, while the average number of circulating shares per person decreased by 24.74% to 57,116 shares [2]. - The stock has experienced significant trading activity, with a net outflow of 1.7647 million yuan in principal funds on November 19, 2025, and a notable presence on the trading leaderboard with a net buy of 39.7092 million yuan on June 6, 2025 [1]. Institutional Holdings - As of September 30, 2025, the second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 17.7822 million shares, a decrease of 3.2169 million shares from the previous period. Other notable shareholders include various mutual funds, with some increasing and others decreasing their holdings [3].

证券代码：300765 证券简称：新诺威 公告编号：2025-088 石药创新制药股份有限公司 关于使用部分闲置募集资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 石药创新制药股份有限公司（以下简称"公司"）于 2025 年 3 月 19 日召开第 六届董事会第二十二次会议、第六届监事会第十七次会议，于 2025 年 4 月 15 日召开 2024 年年度股东大会，会议审议并通过了《关于使用部分闲置募集资金 及自有资金进行现金管理的议案》。在不影响募集资金投资项目建设和公司正常 经营的情况下，公司及子公司使用不超过人民币 8.00 亿元（含本数）额度的闲 置募集资金及不超过人民币 8.00 亿元（含本数）的自有资金进行现金管理，投 资安全性高、流动性好的保本型产品（包括结构性存款、大额存单等），使用期 限自股东大会审议通过之日起 12 个月内有效。在上述额度及决议有效期内，业 务可循环滚动开展。具体内容详见巨潮资讯网（http://www.cninfo.com.cn）披露 的《关于使用部分闲置募集资金及自有资金进行现金管理的公告》（ ...

Core Viewpoint - The stock of XinNuoWei has experienced fluctuations, with a year-to-date increase of 24.73% but a significant decline of 35.29% over the past 60 days, indicating volatility in its market performance [1][2]. Company Overview - XinNuoWei, established on April 5, 2006, and listed on March 22, 2019, is based in Shijiazhuang, Hebei Province. The company focuses on the research, production, and sales of functional foods, with 88.93% of its revenue derived from functional foods and raw materials, 8.91% from biopharmaceuticals, and 2.16% from other sources [1][2]. Financial Performance - For the period from January to September 2025, XinNuoWei reported a revenue of 1.593 billion yuan, reflecting a year-on-year growth of 7.71%. However, the net profit attributable to the parent company was a loss of 24.0489 million yuan, a decrease of 117.26% compared to the previous year [2][3]. Shareholder Information - As of October 31, the number of shareholders for XinNuoWei increased by 32.87% to 21,800, with an average of 57,116 circulating shares per shareholder, down 24.74% from the previous period [2][3]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited holding 17.7822 million shares, a decrease of 3.2169 million shares from the previous period [3]. Dividend Distribution - Since its A-share listing, XinNuoWei has distributed a total of 651 million yuan in dividends, with 500 million yuan distributed over the past three years [3].

期货研究报告|股指及商品策略专题 2025-11-17 股指、贵金属观点与策略 研究院 联系人 汪雅航 wangyahang@htfc.com 从业资格号：F03099648 投资咨询号：Z0019185 蔡劭立 0755-23887993 caishaoli@htfc.com 从业资格号：F3056198 投资咨询号：Z0015616 高聪 021-60828524 gaocong@htfc.com 从业资格号：F3063338 投资咨询号：Z0016648 投资咨询业务资格： 证监许可【2011】1289 号 策略摘要 股指：近期有关部门发布"十五五"规划一些细分领域的指导文件，权益市场长期运行主 线正逐步清晰，长牛行情的趋势无需质疑。短期来看，我国十月经济数据仍在磨底阶段， 中日关系紧张，美国流动性危机尚未过去，受上述海内外多重因素影响，指数呈宽幅震 荡消化态势，市场操作难度依然较高，建议继续通过股指期货进行风险对冲。 黄金：2025-11-14 当周，贵金属延续震荡走势。利率路径方面，美联储内部存在显著分 歧：多名美联储理事释放偏鹰信号；而与此对应的是，美联储理事米兰表示，近期的经 济数据支持了美联储 ...